MADISON RILAND: Open Payments
NPI 1720844160 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,173 in 92 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $404 · 2025 $2,173
Food & beverage: $2,173
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $587 |
| Phathom Pharmaceuticals, Inc. | 6 | $285 |
| Janssen Biotech, Inc. | 16 | $259 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $230 |
| Madrigal Pharmaceuticals | 5 | $162 |
| Celltrion USA Inc. | 4 | $91 |
| Lilly USA, LLC | 4 | $75 |
| Ardelyx, Inc. | 3 | $70 |
| PFIZER INC. | 1 | $58 |
| Novo Nordisk Inc | 3 | $54 |
Products named: TREMFYA, VOQUEZNA, XIFAXAN, LINZESS, REZDIFFRA, RINVOQ, CREON, VEGZELMA.
Industry payments across TX — which companies pay providers there.
